L.-C. Shen, S.-Y. Chiang, I.-T. Ho, K.-Y. Wu, W.-S. Chung
FULL PAPER
was stirred at 0 °C for 30 h. Na2SO3 (1.5 g) was added and the
Table 1. The ESI-MS/MS of 4 and 5 showed the same fragments
mixture was extracted into EtOAc (3ϫ 10 mL). The organic layer at m/z = 430 [M + H]+, 452 [M + Na]+, and 314 [M – 2-deoxyribose
was washed with brine, dried with MgSO4, and evaporated under
reduced pressure on a rotary evaporator. The residue was recrys-
tallized from CH2Cl2 to give 6 as a white solid (86%). Compound
6 showed 96% ee, determined by Chiral HPLC (Figure S7). The
optical rotation of 6, [α]2D5 = +21.7 (c = 0.003, CH2Cl2), was dif-
ferent to the literature value ([α]D = +32).[36] 1H NMR (300 MHz,
+ H]+. HRMS (ESI) for 4: calcd. for C20H24N5O6 [M + H]+
430.1728; found 430.1729. HRMS (ESI) for 5: calcd. for
1
C20H24N5O6 [M + H]+ 430.1728; found 430.1723. The H and 13C
NMR spectroscopic data for 4 and 5 are presented in Tables 2 and
S1, respectively.
(R)-Enriched 4: 1H NMR (500 MHz, [D6]DMSO): δ = 2.29–2.37
(m, 1 H, 2ЈЈ-H), 2.62–2.78 (m, 3 H, 2Ј-H, αЈ, αЈЈ-H), 3.51–3.73 (m,
3 H, 5Ј, 5ЈЈ-H, γЈ-H), 3.87–3.91 (m, 2 H, 4Ј-H, β-H), 4.24–4.29 (m,
1 H, γЈЈ-H), 4.41–4.43 (m, 1 H, 3Ј-H), 6.00 (s, 2 H, g-H), 6.31–6.36
(m, 1 H, 1Ј-H), 6.75 (dd, J1 = 1.6, J2 = 7.9 Hz, 1 H, e-H), 6.86 (d,
J = 7.9 Hz, 1 H, d-H), 6.87 (s, 1 H, a-H), 8.26 (s, 1 H, 2-H), 8.35
(s, 1 H, 8-H) ppm. 13C NMR (125.7 MHz, [D6]DMSO): δ = 40.7
(C-α), 51.4 (C-γ), 61.6 (C-5Ј), 68.5 (C-β), 70.6 (C-3Ј), 83.41 and
83.48 (C-1Ј) overlapped with solvent (C-2Ј), 87.9 (C-4Ј), 100.6 (C-
g), 107.9 (C-d), 109.6 (C-a), 122.1 (C-e), 123.6 (C-5), 132.09 and
132.11 (C-f), 138.74 and 138.79 (C-8), 145.4 (C-c), 146.9 (C-b),
147.07 and 147.12 (C-4), 149.2 (C-2), 156.0 (C-6) ppm.
CDCl3): δ = 2.61–2.74 (m, 2 H, α-H), 3.49 (dd, J1 = 7.0, J2
=
–11.2 Hz, 1 H, γЈ-H), 3.67 (dd, J1 = 3.2, J2 = –11.2 Hz, 1 H, γЈЈ-
H), 3.83–3.91 (m, 1 H, β-H), 5.93 (s, 2 H, g-H), 6.66 (dd, J1 = 1.6,
J2 = 7.9 Hz, 1 H, e-H), 6.72 (d, J = 1.6 Hz, 1 H, a-H), 6.75 (d, J
= 7.9 Hz, 1 H, d-H) ppm. 13C NMR (75.4 MHz, CDCl3): δ = 39.4
(C-α), 65.9 (C-γ), 73.0 (C-β), 100.9 (C-g), 108.3 (C-d), 109.6 (C-a),
122.2 (C-e), 131.3 (C-f), 146.3 (C-c), 147.8 (C-b) ppm.
(R)-(+)- 5-(2-Hydroxy-3-tosyloxypropyl)-1,3-benzodioxole (7): To a
mixture of
6 (0.42 g, 2.14 mmol), tosyl chloride (0.45 g,
2.35 mmol), and 4-dimethylaminopyridine (0.03 g, 0.24 mmol) in
CH2Cl2 (7 mL) was added triethylamine (0.36 mL) in CH2Cl2
(7 mL) dropwise at 0 °C, and the mixture was stirred at room tem-
perature for 3 h. The residue was purified by column chromatog-
raphy (hexane/EtOAc = 75:25, Rf = 0.12) to give 7 as a light yellow
liquid (72%). Compound 7 was determined to have 40% ee by chi-
ral HPLC analysis (Figure S7). [α]2D5 = +12.5 (c = 0.002, CH2Cl2).
1H NMR (300 MHz, CDCl3): δ = 2.46 (s, 3 H, CH3), 2.67–2.71 (m,
2 H, α-H), 3.90–4.06 (m, 3 H, β-H, γЈ-H, γЈЈ-H), 5.93 (s, 2 H, f-
H), 6.59 (dd, J1 = 1.6, J2 = 7.9 Hz, 1 H, e-H), 6.63 (d, J = 1.5 Hz,
1 H, a-H), 6.72 (d, J = 7.9 Hz, 1 H, d-H), 7.34 (d, J = 8.1 Hz, 2
H, Ar-CH), 7.80 (d, J = 8.3 Hz, 2 H, Ar-CH) ppm. 13C NMR
(75.4 MHz, CDCl3): δ = 21.6 (CH3), 38.9 (C-α), 70.3 (C-β), 72.5
(C-γ), 100.9 (C-g), 108.3 (C-d), 109.5 (C-a), 122.2 (C-e), 127.9
(CHCSO3), 129.9 (CH3CCH), 130.2 (C-f), 132.5 (CH3CCH), 145.1
(CHCSO3),146.3 (C-c), 147.7 (C-b) ppm.
1
(R)-Enriched 5: H NMR (500 MHz, [D6]DMSO): δ = 2.30 (ddd,
J2ЈЈ3Ј = 2.9, J1Ј2ЈЈ = 6.1, J2Ј2ЈЈ = –13.1 Hz, 1 H, 2ЈЈ-H), 2.60–2.63 (m,
1 H, αЈ-H), 2.72–2.79 (m, 2 H, 2Ј-H, αЈЈ-H), 3.54 (br. s, γЈ, γЈЈ-H
ovrelap with H2O), 3.54–3.57 (m, 1 H, 5ЈЈ-H), 3.66 (dd, J4Ј5Ј = 3.4,
J5Ј5ЈЈ = –11.7 Hz, 1 H, 5Ј-H), 3.91–3.93 (m, 2 H, 4Ј-H, β-H), 4.44–
4.45 (m, 1 H, 3Ј-H), 5.03 (br. s, 1 H, OH), 5.28 (br. s, 1 H, OH),
5.37 (br. s, 1 H, OH), 5.98 (s, 2 H, g-H), 6.38 (dd, J1Ј2ЈЈ = 6.2, J1Ј2Ј
= 7.7 Hz, 1 H, 1Ј-H), 6.70 (d, J = 7.9 Hz, 1 H, e-H), 6.82 (d, J =
7.9 Hz, 1 H, d-H), 6.84 (s, 1 H, a-H), 7.59 (br. s, 1 H, NH-6), 8.23
(s, 1 H, 2-H), 8.38 (s, 1 H, 8-H) ppm. 13C NMR (125.7 MHz,
[D6]DMSO): δ = 40.7 (C-α), 46.0 (C-γ), 61.9 (C-5Ј), 70.3 (C-β),
71.0 (C-3Ј), 84.0 (C-1Ј) overlapped with solvent (C-2Ј), 88.0 (C-4Ј),
100.6 (C-g), 107.9 (C-d), 109.8 (C-a), 119.7 (C-5), 122.2 (C-e), 133.0
(C-f), 139.5 (C-8), 145.3 (C-c), 146.9 (C-b), 148.1 (C-4), 152.3 (C-
2), 154.6 (C-6) ppm.
Synthesis of (R)-(+)-5-Oxiranylmethyl-1,3-benzodioxole (2): A mix-
ture of 7 (0.13 g, 0.40 mmol) and K2CO3 (0.49 g, 3.57 mmol) in
methanol (25 mL) was stirred at room temperature for 30 min. The
methanol was removed with a rotary evaporator. The residue was
diluted with water and extracted into EtOAc. The organic layer
was dried with MgSO4 and the solvent was removed with a rotary
evaporator. The crude product was purified by column chromatog-
raphy (hexane/EtOAc = 7:3, Rf = 0.58) to give 2 as a light yellow
liquid (23%). Compound 2 was determined to have 39% ee by chi-
ral HPLC analysis (Figure S7). The separated enantiomers were
collected for optical rotation measurements. (R)-(+)-5-Oxiranyl-
methyl-1,3-benzodioxole 2: [α]2D5 = +11.8 (c = 0.003, CH2Cl2); (S)-
(–)-5-Oxiranylmethyl-1,3-benzodioxole 2: [α]2D5 = –11.6 (c = 0.003,
CH2Cl2). [α]2D5 = +13 has been reported for the (R)-(+) enantio-
mer.[36] 1H NMR (300 MHz, CDCl3): δ = 2.47 (dd, J1 = 2.6, J2 =
4.9 Hz, 1 H, γЈ-H), 2.65–2.79 (m, 3 H, γЈЈ-H, αЈ, αЈЈ-H), 3.01–3.07
(m, 1 H, β-H), 5.87 (s, 2 H, CH2), 6.60–6.64 (m, 1 H, Ar-CH), 6.68
(s, 1 H, Ar-CH), 6.95 (d, J = 6.1 Hz, 1 H, Ar-CH) ppm. 13C NMR
(75.4 MHz, in CDCl3): δ = 38.4 (C-γ), 46.8 (C-α), 52.5 (C-β), 100.9
(C-g), 108.3 (C-d), 109.5 (C-a), 121.9 (C-e), 130.8 (C-f), 146.5 (C-
c), 147.7 (C-b) ppm.
Synthesis of [15N5]-4 and [15N5]-5: [15N5]-2Ј-deoxyadenosine (5 mg)
was dissolved in H2O (1 mL) to serve as the stock solution. Com-
pound 2 (20 μmol) was added to [15N5]-2Ј-deoxyadenosine (500 μL,
10 μmol) in 0.2 n K2HPO4 (pH 7.4) buffer solution, and the mix-
ture was incubated at 37 °C for 72 h. The reaction mixture was
subjected to HPLC separation as mentioned above. The corre-
sponding peaks were collected.
Synthesis of N3γ-SFO-Ade (9) and N9γ-SFO-Ade (10): A mixture
of 2 and 8 in a 2:1 molar ratio in 0.2 n K2HPO4 (pH 7.4) buffer
solution was incubated at 37 °C for 72 h. The adducts were purified
and desalted using reverse-phase HPLC. The pure adduct was dried
under vacuum and subjected to spectroscopic and spectrometric
characterization. The characteristic λmax of 9 and 10 at different
pH values are presented in Table 1. The ESI-MS/MS of 9 and 10
showed the same fragments at m/z = 314 [M + H]+ and 136 [M –
SFO + H]+. HRMS (ESI) for 9: calcd. for C15H16N5O3 [M + H]+
314.1255; found 314.1243. HRMS (ESI) for 10: calcd. for
1
C15H16N5O3 [M + H]+ 314.1255; found 314.1242. The H and 13C
NMR spectroscopic data for 9 and 10 are presented in Tables S2
and S3, respectively.
Synthesis of N1γ-SFO-dAdo (4), (R)-Enriched 4, N6γ-SFO-dAdo
(5), and (R)-Enriched 5: A solution of 2 or (R)-(+)-enriched 2 was
treated with 3 in a 2:1 molar ratio in 0.2 n K2HPO4 (pH 7.4) solu-
tion and incubated at 37 °C for 72 h. The products were purified
and desalted using reverse-phase HPLC. Solutions of the pure ad-
ducts were dried under vacuum. Each pure adduct was subjected
to spectroscopic and spectrometric characterization. The character-
istic UV λmax of 4 and 5 at different pH values are presented in
Rearrangement of 4 to N6γ-SFO-dAdo (5): A sample of 4 (30 μg)
in 0.2 n K2HPO4 (1 mL, pH 7.4) solution was incubated at 37 °C,
and the solution was analyzed at various time intervals by reverse-
phase HPLC.
Reaction of 2 with Calf Thymus DNA: Calf thymus DNA (1 mg) in
Tris-HCl buffer (pH 7.5–8.5, 1 mL), which contained 1 mm ethyl-
enediaminetetraacetic acid, was stored at 4 °C overnight to serve
798
www.eurjoc.org
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2012, 792–800